Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2113573 | Cancer Letters | 2011 | 14 Pages |
Abstract
Salubrinal is a specific eIF2α phosphatase inhibitor that inhibits ER stress-mediated apoptosis. However, maintaining hyper-phosphorylated eIF2α state with high doses of salubrinal treatment promotes apoptosis in some cancer cells. In this report, we found that salubrinal induced apoptosis of EBV-transformed B cells. Notably, salubrinal induced ROS generation and p38 MPAK activation, which then induced expression of FasL. Moreover, salubrinal subsequently led to activation of caspases, calcium redistribution, Bax translocation, cytochrome c release, and apoptosis. These findings suggest that salubrinal may be a novel therapeutic approach for EBV-associated malignant diseases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ga Bin Park, Yeong Seok Kim, Hyun-Kyung Lee, Hyunkeun Song, Seonghan Kim, Dae-Ho Cho, Dae Young Hur,